Acetaminophen: When To Use It And When To Say When
Sponsored by Zogenix, Inc.
This activity is not certified for credit.
Date
Wednesday, September 7
3:05 pm - 4:00 pm
Room
Level 3/Gracia 1
Date (Encore)
Saturday, September 10
12:00 pm – 1:30 pm
Lunch will be served
Room
Mont-Royal Ballroom
Program Description
Acetaminophen is one of the most widely used analgesic/antipyretic medications in the United States, with over 25 million doses sold each year. While acetaminophen is safe and effective when used according to directions on nonprescription and prescription labeling, patients and their healthcare professionals are often unaware of the sources of acetaminophen in combination drug products, or the total daily dose of acetaminophen patients are taking. This is particularly important for patients taking multiple medications including acetaminophen/opioid combinations chronically. Join us at this educational program where Mary Lynn McPherson, PharmD, BCPS, CPE, will review the prevalence of acetaminophen use in the US, efficacy data as an analgesic when used as monotherapy and in combination with other analgesics, clinical scenarios where acetaminophen does not contribute additional pain relief, and common toxicities associated with acetaminophen.
Learning Objectives
At the conclusion of this presentation the participant will be able to:
- Describe the pharmacodynamic effects of acetaminophen, and approved indications
- Describe prevalence of acetaminophen use, including both nonprescription and prescription
- Evaluate data on the effectiveness of acetaminophen as monotherapy and in combination with other analgesics
- List common toxicities associated with acetaminophen therapy
- Describe recent FDA actions regarding acetaminophen dosing
- Provide patient educations on the safe use of acetaminophen
Faculty
Mary Lynn McPherson, PharmD BCPS, CPE
Registration
Space is limited for this activity. Please register here.
Contact Name
Redza Ibrahim
Contact Phone
(973) 415-5110
- Pathophysiology of Pain: Mechanisms and Manifestations
- Responsible Opioid Prescribing in the Era of REMS
- Risk Mitigation in Reality: Best Practices from a Transmucosal Fentanyl REMS
- Persistent and Breakthrough Cancer Pain
- Chronic Pain: Best Practices in Interdisciplinary Multimodal Management
